Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-26 @ 2:59 AM
Study NCT ID:
NCT03482102
Status:
RECRUITING
Last Update Posted:
2022-09-08
First Post:
2018-03-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer
Sponsor:
Massachusetts General Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2024-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-10
Completion Date Type:
ESTIMATED
First Submit Date:
2018-03-14
First Submit QC Date:
None
Study First Post Date:
2018-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-07
Last Update Post Date:
2022-09-08
Last Update Post Date Type:
ACTUAL